Codon Usage and Adenovirus Fitness: Implications for Vaccine Development

Judit Giménez-Roig1, Estela Núñez-Manchón1, Ramon Alemany2

  • 1Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.

Summary

Recombinant vaccines use viral vectors to present antigens, mimicking infection for immunity. Novel strategies involve modifying viral gene codon usage for safer, more effective adenoviral vector vaccines.